Resultados da pesquisa - Jessica Howell
- A mostrar 1 - 16 resultados de 16
-
1
Malaria and Victorian Fictions of Empire Por Jessica Howell
Publicado em 2018Livro -
2
Point-of-Care Tests for Hepatitis B: An Overview Por Yinzong Xiao, Alexander Thompson, Jessica Howell
Publicado em 2020Revisão -
3
-
4
-
5
-
6
Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients Por Bridget Draper, Win Lei Yee, Alisa Pedrana, Khin Pyone Kyi, Huma Qureshi, Hla Htay, Win Naing, Alexander Thompson, Margaret Hellard, Jessica Howell
Publicado em 2022Revisão -
7
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib Por Jessica Howell, David J. Pinato, Ramya Ramaswami, Tadaaki Arizumi, Carlotta Ferrari, Antonello Gibbin, Michela Emma Burlone, Giulia Guaschino, Pierluigi Toniutto, James R. Black, Laura Sellers, Masatoshi Kudo, Mario Pirisi, Rohini Sharma
Publicado em 2017Artigo -
8
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma Por Jessica Howell, Stephen R. Atkinson, David J. Pinato, Susanne Knapp, Caroline Ward, Rosalba Minisini, Michela Emma Burlone, Monica Leutner, Mario Pirisi, Reinhard Büttner, Shahid A. Khan, Mark Thursz, Margarete Odenthal, Rohini Sharma
Publicado em 2019Artigo -
9
On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study Por Jessica Howell, David J. Pinato, Ramya Ramaswami, Dominik Bettinger, Tadaaki Arizumi, Cecilia Ferrari, Clarence Yen, Antonello Gibbin, Michela Emma Burlone, Giulia Guaschino, L. Sellers, James R. Black, Mario Pirisi, Masatoshi Kudo, Robert Thimme, J.‐W. Park, Rohini Sharma
Publicado em 2017Artigo -
10
A global investment framework for the elimination of hepatitis B Por Jessica Howell, Alisa Pedrana, Sophia Schroeder, Nick Scott, Lisa Aufegger, Rifat Atun, Ricardo Baptista‐Leite, Gottfried Hirnschall, Ellen ‘t Hoen, Sharon Hutchinson, Jeffrey V. Lazarus, L Olufunmilayo, Raquel Peck, Manik Sharma, Annette H. Sohn, Alexander Thompson, Mark Thursz, David B. Wilson, Margaret Hellard
Publicado em 2020Artigo -
11
Pathway to global elimination of hepatitis B: HBV cure is just the first step Por Jessica Howell, Chris Seaman, Jack Wallace, Yinzong Xiao, Nick Scott, Jane Davies, Teresa De Santis, Danjuma Adda, Manal H. El‐Sayed, Jordan J. Feld, Edward Gane, Karine Lacombe, Olufunmilayo Lesi, Rosmawati Mohamed, Marcelo José Barbosa Silva, Thomas Tu, Peter Revill, Margaret Hellard
Publicado em 2023Revisão -
12
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action Por Jessica Howell, Troy Combo, Paula Binks, Kylie Bragg, Sarah Mariyalawuy Bukulatjpi, Kirsty Campbell, Paul J. Clark, Melissa Carroll, Jane Davies, Teresa De Santis, Kate Muller, Bella Nguyen, John K. Olynyk, Nicholas Shackel, Patricia C. Valery, Alan Wigg, Jacob George, Stuart K. Roberts
Publicado em 2024Artigo -
13
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma Por David J. Pinato, Rohini Sharma, Elias Allara, Clarence Yen, Tadaaki Arizumi, Keiichi Kubota, Dominik Bettinger, Jeong Won Jang, Carlo Smirne, Young Woon Kim, Masatoshi Kudo, Jessica Howell, Ramya Ramaswami, Michela Emma Burlone, Vito Guerra, Robert Thimme, Mitsuru Ishizuka, Justin Stebbing, Mario Pirisi, Brian I. Carr
Publicado em 2016Artigo -
14
Global hepatitis C elimination: an investment framework Por Alisa Pedrana, Jessica Howell, Nick Scott, Sophia Schroeder, Christian Kuschel, Jeffrey V. Lazarus, Rifat Atun, Ricardo Baptista‐Leite, Ellen ‘t Hoen, Sharon Hutchinson, Lisa Aufegger, Raquel Peck, Annette H. Sohn, Tracy Swan, Mark Thursz, Olufunmilayo Lesi, Manik Sharma, John Thwaites, David P. Wilson, Margaret Hellard
Publicado em 2020Revisão -
15
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study Por Maud Lemoine, Yusuke Shimakawa, Ramou Njie, Makie Taal, Gibril Ndow, Isabelle Chemin, S. Monty Ghosh, Harr Freeya Njai, Adam Jeng, A. Sow, Coumba Touré‐Kâne, Souleymane Mboup, Penda Suso, Saydiba Tamba, Abdullah Jatta, Louise Sarr, Aboubacar Kambi, William Stanger, Shevanthi Nayagam, Jessica Howell, Liliane Mpabanzi, Ousman Nyan, Tumani Corrah, Hilton Whittle, Simon D. Taylor‐Robinson, Umberto D’Alessandro, Maimuna Mendy, Mark Thursz
Publicado em 2016Artigo -
16
Innovative strategies for the elimination of viral hepatitis at a national level: A country case series Por Sophia Schroeder, Alisa Pedrana, Nick Scott, David P. Wilson, Christian Kuschel, Lisa Aufegger, Rifat Atun, Ricardo Baptista‐Leite, Maia Butsashvili, Manal H. El‐Sayed, Aneley Getahun, Saeed Hamid, Radi Hammad, Ellen ‘t Hoen, Sharon Hutchinson, Jeffrey V. Lazarus, Olufunmilayo Lesi, Wangsheng Li, Rosmawati Mohamed, Sigurður Ólafsson, Raquel Peck, Annette H. Sohn, Mark Sonderup, C Wendy Spearman, Tracy Swan, Mark Thursz, Tim Walker, Margaret Hellard, Jessica Howell
Publicado em 2019Revisão
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Biology
Hepatitis C
Hepatocellular carcinoma
Liver cancer
Economics
Environmental health
Hepatitis
Hepatitis B
Immunology
Virology
Cirrhosis
Liver disease
Paleontology
Political science
Viral hepatitis
Business
Cancer
Economic growth
Intensive care medicine
Investment (military)
Law
Nursing
Oncology
Pathology
Politics
Public health
Sorafenib
Virus